The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI. Learn more about PI, including the various diagnoses and treatment options.
Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
In an effort to answer some of the most common questions coming in through IDF, we thought that we would address some of the concerns from the CGD Community with Dr. C. Buddy Creech, MD, MPH, Director of the Vanderbilt Vaccine Research Program and Associate Professor of Pediatric Infectious Disease at Vanderbilt University School of Medicine.
Since CGD patients are more at risk for secondary infection due to COVID-19, what can they do to protect themselves?
Self-isolation is key of course. The frequency of secondary bacterial infections, even in adults, has been far less than we would see with influenza. What we have tended to see is ventilator-associated pneumonia, which is a different entity altogether. Therefore, secondary bacterial infections may not be more frequent during this time.
Some individuals with CGD are still considering transplant/curative options such as gene therapy during the COVID-19 pandemic. Should they?
Unfortunately, now may not be the best time for transplantation. There are several factors to consider. First, we don’t know how severe COVID might be in someone in those early days post-transplant. Second, there may be significant shortages of healthcare personnel and beds in the weeks/months to come. Third, there will likely be significant shortages of blood products (red cells, platelets) that are vital in the post-transplant period. In general, I would imagine that non-essential BMT are on hold at most places in the US right now.
Do patients with CGD, carriers, and the general population build up antibodies to COVID-19?
All individuals, including those with CGD, should develop antibodies and cell-mediated immunity (t-cells) following infection with COVID. Therefore, there is no reason to suspect that should a child with CGD develop COVID that they wouldn’t be afforded the same protection. However, we don’t yet know how long – months, years—that others are immune after they’ve recovered.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.
The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.
We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309